References

Low-risk human papillomavirus types in cervical intraepithelial neoplasia 2-3 and in invasive cervical cancer patients

10.1097/lgt.0000000000000486 · 2019 · External reference

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

10.1016/s1470-2045(10)70230-8 · 2010 · External reference

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

10.1016/s0140-6736(13)62218-7 · 2014 · External reference

Applying results of extended genotyping to management of positive cervicovaginal human papillomavirus test results: enduring guidelines

10.1097/lgt.0000000000000865 · 2025 · External reference

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer

10.1002/ijc.27485 · 2012 · External reference

Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review

10.1097/lgt.0000000000000494 · 2020 · External reference

Human papillomavirus same genotype persistence and risk: a systematic review

10.1097/lgt.0000000000000573 · 2021 · External reference

Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study

10.1016/j.ebiom.2024.105149 · 2024 · External reference

The rational design of cervical cancer prevention strategies

10.1016/s0140-6736(24)01547-2 · 2024 · External reference

Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature

10.1016/s0140-6736(24)01097-3 · 2024 · External reference

HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases

10.1038/modpathol.2014.55 · 2014 · External reference

Prevalence and genotype distribution of hpv types in women at risk for cervical neoplasia in Israel

2017 · External reference

Organized primary human papillomavirus-based cervical screening: a randomized healthcare policy trial

10.1371/journal.pmed.1003748 · 2021 · External reference

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

10.1016/s2468-2667(24)00218-4 · 2024 · External reference